MedicaidPrior AuthHigh impact
[Ohio] Updates to Carelon Medical Benefits Management Clinical Appropriateness Guidelines effective
Anthem BCBS·OH · Radiology, Cardiology, Vascular Surgery +3 more·Provider Bulletin
Effective date
Sep 19, 2026
We identified it
Jun 13, 2026
Summary
Carelon Medical Benefits Management has updated clinical appropriateness guidelines effective September 19, 2026, with expansions and modifications across radiology, cardiology, and vascular imaging. Key changes include expanded CT indications for brain perfusion, new vascular imaging criteria (particularly for CTA/MRA), relaxed requirements for some orthopedic imaging (meniscal tears, TFCC instability), modified cardiac device criteria (expanded wearable cardioverter defibrillators and dual-chamber leadless pacemakers), and removal of certain PCI criteria based on recent clinical evidence. Billing teams must review updated approval criteria for imaging and cardiac procedures to ensure proper prior authorization and claims submission.
Action Required
By September 19, 2026: (1) Billing team must update prior authorization rules in billing system to reflect new imaging guidelines for brain CT (perfusion), vascular CTA/MRA (head/neck, stroke, subclavian steal syndrome), and cardiac imaging (coronary calcium CT with 5-10 year repeat intervals, cardiac MRI for cardiomyopathy). (2) Providers must be notified of removed indications: no PCI approval for STEMI with residual non-culprit stenosis, no advanced vascular imaging for syncope, no carotid imaging for syncope. (3) Update internal approval matrices to reflect relaxed requirements: orthopedic imaging (TFCC instability, meniscal tears, osteomyelitis, avascular necrosis) now bypass conservative management requirements; renal artery stenosis screening now requires 3 antihypertensives instead of 4. (4) Cardiac device authorization criteria must be expanded to include non-ischemic cardiomyopathy for wearable cardioverter defibrillators and dual-chamber leadless pacemakers per new clinical evidence. (5) Front-line billing staff should flag claims for duplex ultrasound screening (giant cell arteritis, asymptomatic carotid disease, traumatic vascular injury, pelvic venous disease, subclavian steal syndrome, arterial entrapment syndrome, arteriovenous malformations/fistulas) which now have new approval indications. Claims submitted without alignment to updated criteria will be denied; prior authorizations must be redone for any standing requests.